Welcome to our dedicated page for Acme United SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Acme United Corporation (ACU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8‑K and, through the SEC’s EDGAR system, other periodic and transactional filings that describe Acme United’s financial condition, operations and material events.
Recent Form 8‑K filings for Acme United report material events such as quarterly financial results and financing arrangements. For example, the company has filed 8‑K reports announcing results of operations and financial condition for quarters ended June 30 and September 30, with press releases attached as exhibits. Another 8‑K describes Amendment No. 11 to the company’s Loan and Security Agreement with HSBC Bank USA, N.A., extending the maturity of a secured revolving credit facility.
Through its SEC filings, Acme United discloses information about its jurisdiction of incorporation, commission file number, and principal office location in Shelton, Connecticut. Filings also identify officers who sign the reports and reference attached exhibits, such as loan amendments and earnings press releases. These documents complement the company’s earnings materials by providing formal regulatory context for reported results and financing activities.
On Stock Titan, investors can use AI‑powered tools to review and interpret Acme United’s SEC filings. Real‑time updates from EDGAR surface new 8‑K, 10‑Q, 10‑K and related forms as they are filed, while AI summaries highlight key points such as changes in credit facilities, reported net sales and income figures, and other material disclosures. Users can also locate information relevant to risk factors discussed in forward‑looking statement sections of press releases that are incorporated by reference into SEC filings.
For research on ACU, this filings page serves as a starting point to examine the company’s official regulatory history, including current reports, periodic reports, and material agreements as disclosed to the SEC.
ACME United Corp director and CEO Walter C. Johnsen reported multiple equity compensation transactions. On March 2, 2026, he received a grant of 25,000 employee stock options at an exercise price of $44.77 per share. According to a footnote, 6,250 options vest on each of March 2, 2027, 2028, 2029, and 2030.
On February 27, 2026, he exercised 30,000 employee stock options at $21.49 per share and acquired 30,000 shares of common stock through this derivative exercise. The same day, he disposed of 30,000 common shares to the issuer at $45.88 per share. A footnote states this option exercise was settled on a net cash basis directly with the issuer and did not involve the actual issuance of any underlying common shares.
Acme United Corporation reported modest sales growth but stronger earnings for 2025 and the fourth quarter. Net sales for Q4 2025 rose to $47.5 million from $45.9 million, while net income increased to $1.9 million, or $0.46 per diluted share, up 12% per share from 2024.
For the full year 2025, net sales edged up to $196.5 million from $194.5 million. Net income was $10.2 million, or $2.49 per diluted share, slightly above 2024. The company highlighted tariff-related uncertainty that hurt some U.S. retail promotions but noted strong first aid product sales, robust growth in Europe and Canada, and stable gross margins.
Acme acquired My Medic in January 2026, a tactical and emergency response products business with approximately $19 million in 2025 revenues for a purchase price of $18.7 million. Bank debt less cash fell to $18.1 million as of December 31, 2025, helped by about $13.6 million in free cash flow and investment in a new $6 million Tennessee facility.
Acme United Corporation received an updated large-shareholder disclosure from North Star Investment Management Corporation. As of 12/31/2025, North Star reports beneficial ownership of 252,624 shares of Acme United common stock, representing 6.64% of the outstanding class.
North Star has sole voting and dispositive power over 143,800 shares and shared voting and dispositive power over 108,824 shares. North Star certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Acme United.
The Capital Management Corporation filed an amended Schedule 13G reporting its beneficial ownership of Acme United Corporation common stock as of 12/31/2025. The firm reports beneficial ownership of 540,341.30 shares, representing 14.2% of Acme United’s outstanding common stock.
The Capital Management Corporation has sole voting power over 534,966.30 shares and sole dispositive power over 540,341.30 shares, with no shared voting or dispositive power. The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Acme United.
Acme United Corporation completed an asset acquisition from SLED Distribution, LLC d/b/a "My Medic" and Rapid Medical, LLC, buying substantially all assets of their emergency and first aid products business. The maximum purchase price for the acquired assets is $18,700,000, including $14.6 million paid in cash at closing.
An additional $1,000,000 is contingent on achieving specified revenue milestones during the twelve months ended December 31, 2027, and $3.1 million is subject to a holdback primarily to cover potential indemnification claims. Acme acquired inventory, receivables, equipment, intellectual property, customer and supplier relationships, and certain contracts, while excluding cash, certain contracts, and other non-core items, and only assumed limited specified liabilities. The agreement includes customary representations, warranties, covenants, and indemnification provisions and is governed by Utah law.
Acme United (ACU) reported steady Q3 2025 results. Net sales were $49,063,000, up 2% year over year, with diluted EPS of $0.46 (basic $0.50). Gross margin improved to 39.1% from 38.5%, while SG&A rose to 33.0% of sales. Operating income was $3,007,000, slightly above last year. Net income was $1,903,000 versus $2,226,000 a year ago.
The U.S. segment grew modestly on first aid and medical products, Canada increased 5% (strength in first aid), and Europe rose 13% on e‑commerce school and office products. For the nine months, sales were $149,018,000 and diluted EPS held at $2.03.
Liquidity remained solid: operating cash flow reached $10,079,000 year to date, working capital increased to $76,619,000, and the current ratio improved to 4.47. The company extended its $65 million SOFR+1.75% revolving credit facility to May 31, 2027 and purchased a Mt. Pleasant, TN manufacturing and distribution center for approximately $6.0 million. Management disclosed a previously identified material weakness in IT general controls remains, with remediation expected by December 31, 2025.
Acme United Corporation filed a Form 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025. The company furnished the release as Exhibit 99.1.
The filing lists Item 2.02 (Results of Operations and Financial Condition) and includes the press release dated October 21, 2025. Acme United’s common stock trades on the NYSE American under the symbol ACU.
Richmond Holden Y. Jr., a director of Acme United Corp (ACU), reported option exercise and related share changes on 09/05/2025. He exercised an employee stock option with a $21.20 exercise price covering 2,500 shares; the exercise was settled on a net cash basis directly with the issuer and did not involve issuance of underlying shares. The Form 4 shows a reported acquisition entry of 2,500 shares at $21.20 and a contemporaneous disposition entry of 2,500 shares at $44.36. Following the reported transactions, the filing lists beneficial ownership amounts of 17,750 and 15,250 shares on the non-derivative lines and 16,500 underlying shares reflected under derivative holdings.
Rex Lynn Davidson, a director of Acme United Corp (ACU), reported exercising employee stock options on 08/12/2025 to acquire 2,500 shares of common stock at a price of $43.40 per share. Following the exercise, Davidson directly beneficially owned 29,000 shares. The Form 4 was signed on 08/14/2025. The filing shows a routine option exercise by an insider and records the updated direct ownership.
On August 12-13, 2025, Richmond Y. Holden Jr., a director of Acme United Corp (ACU), exercised employee stock options and completed related transactions. He exercised 2,500 options with a $43.40 exercise price (exercisable and executed 08/12/2025) producing 2,500 underlying shares, and exercised 2,500 options with a $22.60 exercise price (executed 08/13/2025) producing 2,500 underlying shares. Concurrently, 2,500 shares were acquired at $22.66 and 2,500 shares were disposed of via a net cash settlement at an effective price of $44.58, reflecting an exercise settled without issuing shares. Following these transactions, Mr. Holden beneficially owned 21,500 shares from derivative holdings and 15,250 shares direct after the net settlement, per the reporting table.